WO1999020305A8 - Vaccins veterinaires - Google Patents
Vaccins veterinairesInfo
- Publication number
- WO1999020305A8 WO1999020305A8 PCT/AU1998/000865 AU9800865W WO9920305A8 WO 1999020305 A8 WO1999020305 A8 WO 1999020305A8 AU 9800865 W AU9800865 W AU 9800865W WO 9920305 A8 WO9920305 A8 WO 9920305A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- veterinary vaccines
- vaccines
- veterinary
- lambs
- sheep
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2307000A CA2307000C (fr) | 1997-10-17 | 1998-10-16 | Vaccins veterinaires |
NZ503636A NZ503636A (en) | 1997-10-17 | 1998-10-16 | Vaccines for the prevention of clostridial diseases of sheep that provide effective immunity for up to a year or more from a single dose |
PCT/AU1998/000865 WO1999020305A1 (fr) | 1997-10-17 | 1998-10-16 | Vaccins veterinaires |
US09/509,961 US6524592B2 (en) | 1997-10-17 | 1998-10-16 | Veterinary vaccines |
AU96161/98A AU753804B2 (en) | 1997-10-17 | 1998-10-16 | Veterinary vaccines |
EP98949828A EP1023083A4 (fr) | 1997-10-17 | 1998-10-16 | Vaccins veterinaires |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9722035.4 | 1997-10-17 | ||
GBGB9722035.4A GB9722035D0 (en) | 1997-10-17 | 1997-10-17 | Veterinary vaccines |
PCT/AU1998/000865 WO1999020305A1 (fr) | 1997-10-17 | 1998-10-16 | Vaccins veterinaires |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999020305A1 WO1999020305A1 (fr) | 1999-04-29 |
WO1999020305A8 true WO1999020305A8 (fr) | 1999-07-08 |
Family
ID=25641911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU1998/000865 WO1999020305A1 (fr) | 1997-10-17 | 1998-10-16 | Vaccins veterinaires |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1023083A4 (fr) |
AU (1) | AU753804B2 (fr) |
CA (1) | CA2307000C (fr) |
NZ (1) | NZ503636A (fr) |
WO (1) | WO1999020305A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2824279B1 (fr) * | 2001-05-04 | 2004-05-28 | Seppic Sa | Emulsion e/h concentree |
FR2824269B1 (fr) * | 2001-09-03 | 2012-03-02 | Seppic Sa | Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras |
WO2007068055A1 (fr) * | 2005-12-15 | 2007-06-21 | Hancroft Pty Ltd | Procede de prevention de la diminution de la prise alimentaire chez l'animal et traitement de maladies |
FR2903602B1 (fr) * | 2006-07-12 | 2012-10-26 | Seppic Sa | Formulation injectable a liberation prolongee de principes actifs, procede pour sa preparation |
FR2922767B1 (fr) | 2007-10-24 | 2009-12-18 | Seppic Sa | Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant. |
CN106177935A (zh) * | 2016-08-19 | 2016-12-07 | 齐鲁动物保健品有限公司 | 一种反刍动物梭菌病四联灭活疫苗及其制备方法 |
GB201718251D0 (en) * | 2017-11-03 | 2017-12-20 | Univ Sydney | Vaccine Compositions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1128325A (en) * | 1964-11-11 | 1968-09-25 | Wellcome Found | Improvements in water-in-oil emulsion vaccines |
US3843451A (en) * | 1970-08-20 | 1974-10-22 | Burroughs Wellcome Co | Microorganism production |
FR2649012B1 (fr) | 1989-07-03 | 1991-10-25 | Seppic Sa | Emulsions multiphasiques injectables |
FR2717694B1 (fr) * | 1994-03-22 | 1996-05-03 | Seppic Sa | Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament. |
DE69636889T2 (de) * | 1995-11-30 | 2007-12-06 | Nof Corp. | Öladjuvierter Impfstoff und Verfahren zu seiner Herstellung |
GB9626865D0 (en) | 1996-12-24 | 1997-02-12 | Cyanamid Websters Pty Limited | Veterinary vaccines |
-
1998
- 1998-10-16 NZ NZ503636A patent/NZ503636A/en not_active IP Right Cessation
- 1998-10-16 WO PCT/AU1998/000865 patent/WO1999020305A1/fr active IP Right Grant
- 1998-10-16 EP EP98949828A patent/EP1023083A4/fr not_active Withdrawn
- 1998-10-16 AU AU96161/98A patent/AU753804B2/en not_active Expired
- 1998-10-16 CA CA2307000A patent/CA2307000C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2307000A1 (fr) | 1999-04-29 |
EP1023083A4 (fr) | 2006-06-14 |
AU9616198A (en) | 1999-05-10 |
AU753804B2 (en) | 2002-10-31 |
NZ503636A (en) | 2002-05-31 |
CA2307000C (fr) | 2011-01-04 |
WO1999020305A1 (fr) | 1999-04-29 |
EP1023083A1 (fr) | 2000-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2322801B (en) | Vaccine compositions for intranasal administration comprising chitosan and use thereof | |
HK1030753A1 (en) | Fracture healing using pthrp analogs. | |
ZA975943B (en) | Aqueous formulations of peptides. | |
AUPM969994A0 (en) | Equine anthelmintic formulations | |
ZA98361B (en) | Hypodermic injection system. | |
DE69021387T3 (de) | Medizinische aerosolformulierungen. | |
ZA969722B (en) | Pharmaceutical formulations. | |
EP0671902A4 (fr) | THERAPIE DES TOXI-INFECTIONS AU -i(CLOSTRIDIUM). | |
AU3699397A (en) | Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases | |
EP0680337A4 (fr) | Procedes et compositions pour application directe a forte concentration d'anticorps, produisant une immunite passive. | |
NO902441D0 (no) | Aromautleveringssystem, samt tyggegummiblanding. | |
DZ2283A1 (fr) | Composition de vaccin. | |
WO1999020305A8 (fr) | Vaccins veterinaires | |
WO1999002143A3 (fr) | Composition contenant un nucleotide | |
BR9608255A (pt) | Sistema terapéutico transdérmico (stt) para a administração de testosterona | |
TR199501082A2 (tr) | Farmasötik formülasyonlar. | |
WO1998040097A3 (fr) | Coronavirus respiratoire bovin utilise comme vaccin | |
WO1999057278A3 (fr) | Immunisation et traitement anti-infectieux | |
WO1999058145A3 (fr) | Vaccin | |
ZA962461B (en) | Low dose ridogrel formulations. | |
ES2184987T3 (es) | Formas de administracion solidas de liberacion instantanea y procedimiento para su preparacion. | |
ZA975586B (en) | Recombinant vaccine for diseases caused by encapsulated organisms. | |
EP0663209A3 (fr) | Médicament pour inhiber les effets des protéines amyloidogéniques. | |
DE69513760D1 (de) | Auf Helicobacter pylori Katalase basierende immunisierende Zusammensetzung | |
EP0597130A4 (en) | Antirheumatic. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 503636 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998949828 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2307000 Country of ref document: CA Kind code of ref document: A Ref document number: 2307000 |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 96161/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09509961 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1998949828 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 96161/98 Country of ref document: AU |